Overview
- A planned invite-only “Peptide Party” in Bengaluru was cancelled after the Karnataka Food Safety and Drug Administration asked organisers to produce details on composition, manufacturers, regulatory status, dosage and intended use.
- Journalists and doctors say the cancellation highlights a wider urban trend of people in Indian metros sourcing peptides online, following social-media protocols, and sometimes self-injecting without medical supervision or prescriptions.
- Experts warn many compounds being sold as wellness peptides — names include BPC-157, TB-500, epitalon and MOTS-c — lack robust human trial evidence and are often marketed as ‘research chemicals’ that may be mislabelled or contaminated.
- Public-health risks include unknown contents, wrong concentrations, contamination, infection from unsafe injection practices, unpredictable hormone or metabolic effects, and added danger when users combine multiple peptides.
- Voices calling for action include senior pharmacologists and doctors, while the US FDA has advised against compounding BPC-157; authorities and consumers should watch for stricter oversight from national regulators and enforcement of sales channels.